Cizzle Biotechnology Holdings PLC (GB:CIZ) has released an update.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Cizzle Biotechnology Holdings PLC, a UK-based developer of diagnostic technologies, has successfully passed all resolutions during its recent Annual General Meeting, including the re-appointment of key directors and the re-appointment of PKF Littlejohn LLP as the company’s auditor. Shareholders showed strong support with high percentages of votes cast in favor of the proposed resolutions. The company, which emerged from the University of York, is focused on innovating early detection of lung cancer through a blood test that identifies the CIZ1B biomarker.
For further insights into GB:CIZ stock, check out TipRanks’ Stock Analysis page.